Serial analysis of gene expression reveals promising therapeutic targets for liver fluke-associated cholangiocarcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue SUPPL.1, 2012, Pages 89-93

  Sawanyawisuth, Kanlayanee ^a   Wongkham, Chaisiri ^a   Araki, Norie ^b   Zhao, Qi ^c   Riggins, Gregory J ^c   Wongkham, Sopit ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KUMAMOTO UNIVERSITY   (Japan)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bile duct cancer; Cholangiocarcinoma; SAGE; Serial analysis of gene expression

Indexed keywords

ANIMAL; BILE DUCT CARCINOMA; BILE DUCT TUMOR; FASCIOLA HEPATICA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; INTRAHEPATIC BILE DUCT;

ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FASCIOLA HEPATICA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS;

EID: 84874045066     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.KKSuppl.89     Document Type: Article

References (35)

1. Albrechtsson E, Jonsson T, Moller S, et al (2003). Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases cell number. Pancreatology, 3, 41-6.
2. Banerjee P, Chatterjee M (2003). Antiproliferative role of vitamin D and its analogs-a brief overview. Mol Cell Biochem, 253,247-54.
3. Boon K, Osorio EC, Greenhut SF, et al (2002). An anatomy of normal and malignant gene expression. Proc Natl Acad Sci USA, 99, 11287-92.
4. Bordador LC, Li X, Toole B, et al (2000). Expression of emmprin by oral squamous cell carcinoma. Int J Cancer, 85, 347-52.
5. Campa MJ, Wang MZ, Howard B, et al (2003). Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer. Cancer Res, 63, 1652-6.
6. Castronovo V, Van Den Brule FA, Jackers P, et al (1996). Decreased expression of galectin-3 is associated with progression of human breast cancer. J Pathol, 179, 43-8.
7. Chen C, Li M, Yang H, et al (2005). Roles of thymosins in cancers and other organ systems. World J Surg, 29, 264-70.
8. Chen ZN, Mi L, Xu J, et al (2006). Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials. Int J Radiat Oncol Biol Phys, 65, 435-44.
9. Cross HS, Bareis P, Hofer H, et al (2001). 25-Hydroxyvitamin D(3)-1alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids, 66, 287-92.
10. Datson NA, van der Perk-de Jong J, van den Berg MP, et al (1999). MicroSAGE: a modified procedure for serial analysis of gene expression in limited amounts of tissue. Nucleic Acids Res, 27, 1300-7.
11. Friedrich M, Rafi L, Tilgen W, et al (1998). Expression of 1,25-dihydroxy vitamin D3 receptor in breast carcinoma. J Histochem Cytochem, 46, 1335-7.
12. Handschumacher RE, Harding MW, Rice J, et al (1984). Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science, 226, 544-7.
13. Howard BA, Zheng Z, Campa MJ, et al (2004). Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer. Lung Cancer, 46, 313-23.
14. Junking M, Wongkham C, Sripa B, et al (2008). Decreased expression of galectin-3 is associated with metastatic potential of liver fluke-associated cholangiocarcinoma. Eur J Cancer, 44, 619-26.
15. Kanekura T, Chen X, Kanzaki T (2002). Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int J Cancer, 99, 520-8.
16. Kim SH, Lessner SM, Sakurai Y, et al (2004). Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction. Am J Pathol, 164, 1567-74.
17. Li M, Zhai Q, Bharadwaj U, et al (2006). Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. Cancer, 106, 2284-94.
18. Nabeshima K, Iwasaki H, Koga K, et al (2006). Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int, 56, 359-67.
19. Nishino R, Honda M, Yamashita T, et al (2008). Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma. J Hepatol, 49, 207-16.
20. Obama K, Ura K, Li M, et al (2005). Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma. Hepatology, 41, 1339-48.
21. Obchoei S, Weakley SM, Wongkham S, et al (2011). Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma. Mol Cancer, 10, 102.
22. Omi Y, Shibata N, Okamoto T, et al (2012). The role of CD147 in the invasiveness of follicular thyroid carcinoma cells. Thyroid, 22, 383-94.
23. Patel T (2002). Worldwide trends in mortality from biliary tract malignancies. BMC Cancer, 2, 10.
24. Pelczynska M, Wietrzyk J, Jaroszewicz I, et al (2005). Correlation between VDR expression and antiproliferative activity of vitamin D3 compounds in combination with cytostatics. Anticancer Res, 25, 2235-40.
25. Polette M, Gilles C, Marchand V, et al (1997). Tumor collagenase stimulatory factor (TCSF) expression and localization in human lung and breast cancers. J Histochem Cytochem, 45, 703-9.
26. Seubwai W, Wongkham C, Puapairoj A, et al (2007). Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics. Cancer, 109, 2497-505.
27. Seubwai W, Wongkham C, Puapairoj A, et al (2010). 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma. Cancer, 116, 5535-43.
28. Sherry B, Yarlett N, Strupp A, et al (1992). Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages. Proc Natl Acad Sci USA, 89, 3511-5.
29. Shimonishi T, Miyazaki K, Kono N, et al (2001). Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma. Hum Pathol, 32, 302-10.
30. Shin HR, Oh JK, Masuyer E, et al (2010). Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma--focus on East and South-Eastern Asia. Asian Pac J Cancer Prev, 11, 1159-66.
31. Sribenja S, Li M, Wongkham S, et al (2009). Advances in thymosin beta10 research: differential expression, molecular mechanisms, and clinical implications in cancer and other conditions. Cancer Invest, 27, 1016-22.
32. Sripa B, Kaewkes S, Sithithaworn P, et al (2007). Liver fluke induces cholangiocarcinoma. PLoS Med, 4, e201.
33. Velculescu VE, Zhang L, Vogelstein B, et al (1995). Serial analysis of gene expression. Science, 270, 484-7.
34. Wang AG, Yoon SY, Oh JH, et al (2006). Identification of intrahepatic cholangiocarcinoma related genes by comparison with normal liver tissues using expressed sequence tags. Biochem Biophys Res Commun, 345, 1022-32.
35. Yang H, Li M, Chai H, et al (2005). Effects of cyclophilin A on cell proliferation and gene expressions in human vascular smooth muscle cells and endothelial cells. J Surg Res, 123, 312-9.